Biggest News Aggregation in the World
📰 Closing News

Page 984 - Closing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Closing. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Biocytogen Subsidiary, Eucure Biopharma, Announces the First Patient Dosing for a Phase I Multi-regional Clinical Trial of YH002 (Anti-OX40 mAb) in Combination with YH001 (Anti-CTLA-4 mAb) in Australia

BEIJING, March 8, 2022 /PRNewswire/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-regional clinical trial (MRCT) of YH002
United States Haimen Jiangsu Prnewswire Eucure Biopharma Kostenloser Wertpapierhandel Yuelei Shen Eucure Biopharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science